Publications

We will regularly update this page with links to our publications

Safety of the first dose of mRNA SARS- CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases

Antibody response to the Janssen/Johnson & Johnson SARS- CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases

Disease Flare and Reactogenicity in Patients with Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination

Booster- dose SARS- CoV-2 vaccination in patients with autoimmune disease: a case series

Antibody kinetics in patients with rheumatic diseases after SARSCoV-2 mRNA vaccination

Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series

High antibody response to two- dose SARS- CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases

Antibody response to a single dose of SARS- CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases

Attenuated response to fourth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series

Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series